Search - tctmd.com

Displaying 781 - 800 of 981

Sort: Relevancy | Date

Presentation TCT 2014

Landscape Highlights of New Transfemoral Access-Closure Devices

Presenter: Alexandre Abizaid

September 15, 2014

Presentation TCT 2014

Cardiac Flow Imaging: Visions of Structural Heart Disease on the Morpheus Cloud

Presenter: Susheel Kodali, Nicolo Piazza, Lutz Buellesfeld, Albert Hsiao

September 15, 2014

Presentation TCT 2014

Keystone Deflector Device - Technology Overview and Clinical Trial Status (DEFLECT I and Other Trials)

Presenter: Alexandra J. Lansky

September 15, 2014

Presentation TCT 2014

First Use of an Objective and Reproducible Method for Quantification of Aortic Regurgitation After TAVR Based on Angiography

Presenter: Susheel Kodali, Nicolo Piazza, Lutz Buellesfeld, Carl Schultz

September 15, 2014

Presentation TCT 2014

Introduction to the US FDA-Approved Sentinel TAVR Safety and Efficacy Study

Presenter: Susheel Kodali

September 15, 2014

Presentation TCT 2014

Technology Overview and Status of the CLEAN-TAVI Randomized Trial

Presenter: Martin B. Leon

September 15, 2014

Presentation TCT 2014

Embrella Deflector Device -Technology Overview and Clinical Trial Status (Pilot Phase of PROTAVI C and Beyond)

Presenter: Alec S. Vahanian

September 15, 2014

Presentation TCT 2014

An Update of New Aortic Valvuloplasty and Valve Remodeling Technologies

Presenter: Martin B. Leon

September 15, 2014

Presentation TCT 2014

The Five Multislice CT Essentials for Optimal TAVR

Presenter: Alain G. Cribier, Michael J. Reardon, Steven J. Yakubov, Jonathon A. Leipsic

September 14, 2014

Presentation TCT 2014

The Five Echocardiographic Essentials for Optimal TAVR

Presenter: Alain G. Cribier, Michael J. Reardon, Steven J. Yakubov, Rebecca T. Hahn

September 14, 2014

Presentation TCT 2014

Multi-device Patient-Specific TAVR Now or in the Future?

Presenter: Alain G. Cribier, Michael J. Reardon, Steven J. Yakubov, Raj Makkar

September 14, 2014

Presentation TCT 2014

Lessons From the CHOICE Trial

Presenter: Alain G. Cribier, Michael J. Reardon, Steven J. Yakubov, Mohamed Abdel-Wahab

September 14, 2014

Presentation TCT 2014

Special Attributes and Disadvantages of the Balloon-Expandable TAVR Platform

Presenter: Alain G. Cribier, Michael J. Reardon, Steven J. Yakubov, John G. Webb

September 14, 2014

Presentation TCT 2014

Special Attributes and Disadvantages of the Self-Expanding TAVR Platform

Presenter: Alain G. Cribier, Michael J. Reardon, Steven J. Yakubov, Nicolo Piazza

September 14, 2014

Presentation TCT 2014

Case #2: Transfemoral TAVR for Bicuspid Aortic Valve Stenosis Using a Second-Generation Device

Presenter: Graham A. Cassel, Hans R. Figulla, Greg L. Kaluza, Jochen Wöhrle, Peter Boekstegers

September 14, 2014

Presentation TCT 2014

Which of the Newer-Generation TAVR Devices Would I Like to Have Available in the United States?

Presenter: Markus Kasel, Ted E. Feldman

September 13, 2014

Presentation TCT 2014

Case #1: TAVR with a Repositionable Device: Does Multiple Repositioning Avoid Paravalvular Aortic Regurgitation?

Presenter: Markus Kasel, Joachim Schofer

September 13, 2014

Presentation TCT 2014

Newer-Generation Devices for Valve Implantation: Differentiating Features

Presenter: Markus Kasel, Hans R. Figulla

September 13, 2014

Presentation TCT 2014

ISAR-CLOSURE: A Prospective, Randomized Trial of Two Vascular Closure Devices Versus Manual Compression After Femoral Artery Access

Presenter: Robert J. Applegate, Ronald Caputo, Stefanie Schüpke

September 13, 2014

Presentation TCT 2014

Impact of TAVR Design on Technical Success: Opportunities for and Challenges of Current and Future TAVR Technologies

Presenter: Mark Reisman

September 13, 2014

Advertisement

Landscape Highlights of New Transfemoral Access-Closure Devices

Cardiac Flow Imaging: Visions of Structural Heart Disease on the Morpheus Cloud

Keystone Deflector Device - Technology Overview and Clinical Trial Status (DEFLECT I and Other Trials)

First Use of an Objective and Reproducible Method for Quantification of Aortic Regurgitation After TAVR Based on Angiography

Introduction to the US FDA-Approved Sentinel TAVR Safety and Efficacy Study

Technology Overview and Status of the CLEAN-TAVI Randomized Trial

Embrella Deflector Device -Technology Overview and Clinical Trial Status (Pilot Phase of PROTAVI C and Beyond)

An Update of New Aortic Valvuloplasty and Valve Remodeling Technologies

The Five Multislice CT Essentials for Optimal TAVR

The Five Echocardiographic Essentials for Optimal TAVR

Multi-device Patient-Specific TAVR Now or in the Future?

Lessons From the CHOICE Trial

Special Attributes and Disadvantages of the Balloon-Expandable TAVR Platform

Special Attributes and Disadvantages of the Self-Expanding TAVR Platform

Case #2: Transfemoral TAVR for Bicuspid Aortic Valve Stenosis Using a Second-Generation Device

Which of the Newer-Generation TAVR Devices Would I Like to Have Available in the United States?

Case #1: TAVR with a Repositionable Device: Does Multiple Repositioning Avoid Paravalvular Aortic Regurgitation?

Newer-Generation Devices for Valve Implantation: Differentiating Features

ISAR-CLOSURE: A Prospective, Randomized Trial of Two Vascular Closure Devices Versus Manual Compression After Femoral Artery Access

Impact of TAVR Design on Technical Success: Opportunities for and Challenges of Current and Future TAVR Technologies

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content